Sabra Health Care REIT, Inc. (SBRA)
| Market Cap | 5.23B +25.7% |
| Revenue (ttm) | 815.66M +13.2% |
| Net Income | 156.19M +11.0% |
| EPS | 0.63 +5.3% |
| Shares Out | 252.19M |
| PE Ratio | 32.92 |
| Forward PE | 29.52 |
| Dividend | $1.20 (5.78%) |
| Ex-Dividend Date | May 15, 2026 |
| Volume | 1,589,555 |
| Open | 20.66 |
| Previous Close | 20.58 |
| Day's Range | 20.64 - 20.93 |
| 52-Week Range | 17.08 - 21.07 |
| Beta | 0.65 |
| Analysts | Buy |
| Price Target | 22.00 (+6.02%) |
| Earnings Date | Apr 29, 2026 |
About SBRA
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 in Maryland.
Financial Performance
In 2025, Sabra Health Care REIT's revenue was $775.76 million, an increase of 10.41% compared to the previous year's $702.64 million. Earnings were $155.61 million, an increase of 22.81%.
Financial StatementsAnalyst Summary
According to 8 analysts, the average rating for SBRA stock is "Buy." The 12-month stock price target is $22.0, which is an increase of 6.02% from the latest price.
News
Sabra Health Care REIT Earnings Call Transcript: Q1 2026
Strong Q1 results with robust investment activity, sequential and year-over-year growth in managed senior housing, and continued margin expansion. Guidance for 2026 was reaffirmed, with a focus on SHOP growth, AI initiatives, and a healthy balance sheet supporting future investments.
Sabra Reports First Quarter 2026 Results; Reiterates 2026 Guidance
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #1Q26--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the first quarter of 2026. F...
Sabra Health Care REIT, Inc. to Attend Wells Fargo's 29th Annual Real Estate Securities Conference
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #SBRA--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the compa...
Sabra Health Care REIT, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #1Q26--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2026 first quarter earnings release on April 29, 2026, after the clo...
REITs Have Been Rocked, These 4 Now Pay Up To 14.6%
Oil is up, and everything else is down. Stocks. Bonds.
Sabra Health Care price target raised to $22 from $21 at Wells Fargo
Wells Fargo analyst John Kilichowski raised the firm’s price target on Sabra Health Care (SBRA) to $22 from $21 and keeps an Overweight rating on the shares. The firm continues
Sabra Health Care REIT, Inc. to Attend the 2026 NIC Spring Conference
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #SBRA--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Darrin Smith, the compan...
Sabra Health Care price target raised to $22 from $21 at Truist
Truist analyst Michael Lewis raised the firm’s price target on Sabra Health Care (SBRA) to $22 from $21 and keeps a Hold rating on the shares. The firm sees good
Sabra Health Care REIT, Inc. to Participate in Deutsche Bank's 2026 Healthcare REIT Summit
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #DBSummit--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the c...
Sabra Health Care price target raised to $21 from $20 at Scotiabank
Scotiabank analyst Nicholas Yulico raised the firm’s price target on Sabra Health Care (SBRA) to $21 from $20 and keeps a Sector Perform rating on the shares. The firm is
Sabra Health Care price target raised to $21 from $20 at UBS
UBS analyst Michael Goldsmith raised the firm’s price target on Sabra Health Care (SBRA) to $21 from $20 and keeps a Neutral rating on the shares.
Sabra Health Care price target raised to $24 from $21 at Citi
Citi analyst Nick Joseph raised the firm’s price target on Sabra Health Care (SBRA) to $24 from $21 and keeps a Buy rating on the shares.
Sabra Health Care price target raised to $23 from $22 at BofA
BofA analyst Farrell Granath raised the firm’s price target on Sabra Health Care (SBRA) to $23 from $22 and keeps a Buy rating on the shares. The firm updated estimates
Sabra Health Care price target raised to $21 from $20 at Cantor Fitzgerald
Cantor Fitzgerald analyst Richard Anderson raised the firm’s price target on Sabra Health Care (SBRA) to $21 from $20 and keeps a Neutral rating on the shares. While the company
Sabra Health Care REIT, Inc. to Attend Citi's 2026 Global Property CEO Conference
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #CITI--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer; Michael Costa, the compa...
Sabra Health Care REIT Earnings Call Transcript: Q4 2025
Strong Q4 results driven by SHOP and senior housing, with robust investment activity and a positive 2026 outlook. Guidance calls for ~5% growth in normalized FFO/AFFO per share, supported by high liquidity and stable leverage.
Sabra Reports Fourth Quarter 2025 Results; Introduces 2026 Guidance
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #4Q25--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the fourth quarter of 2025. ...
Sabra Health Care REIT, Inc. Announces Fourth Quarter 2025 Earnings Release Date and Conference Call; Declares Common Dividend
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #4Q25--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2025 fourth quarter earnings release on February 12, 2026, after the...
Sabra Health Care REIT, Inc. Announces Tax Treatment of 2025 Distributions
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #2025tax--Sabra Health Care REIT, Inc. (NASDAQ: SBRA) announced today the tax treatment for its 2025 distributions. The following table summarizes, for income...
Sabra Health Care price target raised to $21 from $20 at Truist
Truist analyst Michael Lewis raised the firm’s price target on Sabra Health Care (SBRA) to $21 from $20 and keeps a Hold rating on the shares. The firm adjusted ratings
Sabra Health Care names Darrin Smith chief investment officer
Sabra Health Care (SBRA) REIT announced that Darrin Smith has been appointed as chief investment officer, secretary, and executive VP, effective January 1. Smith succeeds Talya Nevo-Hacohen, who retir...
Sabra Health Care REIT, Inc. Appoints Darrin Smith as Chief Investment Officer and Congratulates Talya Nevo-Hacohen on her Retirement
TUSTIN, Calif.--(BUSINESS WIRE)---- $CIO #CIO--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced that Darrin Smith has been appointed Sabra's Chief Investment Officer, Secretary an...
CNBC's Investment Committee's Top Picks for 2026: Amazon, Sabra and Visa
The Investment Committee detail their top picks for 2026 and explain why these names are may go higher during the year.
Sabra Health Care price target raised to $22 from $21 at Jefferies
Jefferies analyst Joe Dickstein raised the firm’s price target on Sabra Health Care (SBRA) to $22 from $21 and keeps a Buy rating on the shares as part of a